FDA Adverse Event
Injury
Summary report: N
CREATININE PLUS SYSTEM PACK
MDR report key: 118827
·
Received September 8, 1997
Report
- Report Number
- 1823260-1997-00075
- Event Type
- Injury
- Date Received
- September 8, 1997
- Date of Event
- July 26, 1997
- Report Date
- July 26, 1997
- Manufacturer
- BOEHRINGER MANNHEIM CORP.
- Product Code
- CGL
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- OH, US
- Reporter Occupation
- OTHER
Narratives
Description of Event or Problem · 1
CANCER PATIENT WITH UNSPECIFIED "ILLNESS" WAS HOSPITALIZED BASED ON A CREATININE RESULT OF 13.8 MG/DL FROM THE SUSPECT DEVICE. THE FOLLOWING DAY, AN ALTERNATE METHOD (JAFFE REACTION) WAS USED TO ASSAY THE SAMPLE WITH A RESULT OF 2.0 MG/DL. THE TREATING PHYSICIAN BELIEVED THE 2.0 MG/DL VALUE BETTER FIT THE PATIENT'S CONDITION. THE PATIENT WAS TRANSFUSED WITH 2 UNITS OF BLOOD, BUT THE REPORTING TECHNICIAN DID NOT KNOW IF THIS WAS BEFORE OR AFTER THE CREATININE TEST.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | CREATININE PLUS SYSTEM PACK | CREATININE REAGENT | CGL | BOEHRINGER MANNHEIM CORP. | R1/R2 | 67848101/67846201 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 86 YR | Hospitalization |